Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) - Macdonald, R L; Higashida, R T; Keller, E; Mayer, S A; Molyneux, A; Raabe, A (Lancet Neurol, 2011)
et al.